000 | 01732 a2200493 4500 | ||
---|---|---|---|
005 | 20250516234556.0 | ||
264 | 0 | _c20161101 | |
008 | 201611s 0 0 eng d | ||
022 | _a1369-1600 | ||
024 | 7 |
_a10.1111/adb.12185 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aYusoff, Nurul H M | |
245 | 0 | 0 |
_aAbuse potential and adverse cognitive effects of mitragynine (kratom). _h[electronic resource] |
260 |
_bAddiction biology _cJan 2016 |
||
300 |
_a98-110 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAnti-Anxiety Agents _xpharmacology |
650 | 0 | 4 |
_aAvoidance Learning _xdrug effects |
650 | 0 | 4 |
_aBehavior, Animal _xdrug effects |
650 | 0 | 4 |
_aDelta Rhythm _xdrug effects |
650 | 0 | 4 |
_aDopamine Plasma Membrane Transport Proteins _xdrug effects |
650 | 0 | 4 |
_aKruppel-Like Transcription Factors _xdrug effects |
650 | 0 | 4 |
_aLocomotion _xdrug effects |
650 | 0 | 4 |
_aMemory Consolidation _xdrug effects |
650 | 0 | 4 | _aMice |
650 | 0 | 4 |
_aRNA, Messenger _xdrug effects |
650 | 0 | 4 | _aRats |
650 | 0 | 4 |
_aSecologanin Tryptamine Alkaloids _xpharmacology |
650 | 0 | 4 | _aSubstance-Related Disorders |
650 | 0 | 4 |
_aTheta Rhythm _xdrug effects |
700 | 1 | _aSuhaimi, Farah W | |
700 | 1 | _aVadivelu, Raja K | |
700 | 1 | _aHassan, Zurina | |
700 | 1 | _aRümler, Anne | |
700 | 1 | _aRotter, Andrea | |
700 | 1 | _aAmato, Davide | |
700 | 1 | _aDringenberg, Hans C | |
700 | 1 | _aMansor, Sharif M | |
700 | 1 | _aNavaratnam, Visweswaran | |
700 | 1 | _aMüller, Christian P | |
773 | 0 |
_tAddiction biology _gvol. 21 _gno. 1 _gp. 98-110 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/adb.12185 _zAvailable from publisher's website |
999 |
_c24229181 _d24229181 |